Please use this identifier to cite or link to this item:
https://hdl.handle.net/1959.11/16316
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Sharpley, Christopher | en |
dc.contributor.author | Christie, David R H | en |
dc.contributor.author | Bitsika, Vicki | en |
dc.contributor.author | Oar, Andrew J | en |
dc.date.accessioned | 2014-12-17T15:40:00Z | - |
dc.date.issued | 2014 | - |
dc.identifier.citation | International Journal of Clinical Oncology, 19(6), p. 1080-1084 | en |
dc.identifier.issn | 1437-7772 | en |
dc.identifier.issn | 1341-9625 | en |
dc.identifier.uri | https://hdl.handle.net/1959.11/16316 | - |
dc.description.abstract | Objective: To compare the prevalence of depressive symptoms between prostate cancer (PCa) patients who have received low-dose rate brachytherapy (LDRB) and those receiving high-dose-rate brachytherapy (HDRB). Method: Direct comparisons were made between the prevalence of the DSM-IV-TR symptoms of major depressive disorder (MDD) based upon Zung Self-Rating Depression Scale responses and patients' records on 164 PCa patients from Queensland, Australia. Results: HDRB patients had significantly greater frequency of self-reported symptoms of crying (or feeling like it) (MDD criterion 1), and restlessness and inability to sit still (MDD criterion 5), and a nonsignificant trend towards more frequent fatigue (MDD criterion 7). There was no significant association between fatigue and having received hormone therapy. Conclusion: These three MDD symptoms, which include one of the two alternative key required symptoms (criterion 1), suggest that HDRB PCa patients may present with clinically significantly different depression profiles from their peers who receive LDRB. Treatment choices need to be focused upon possible serotonergic dysfunction as well as somatic complaints of depression. The presence of subsyndromal depression in HDRB patients also warrants consideration. | en |
dc.language | en | en |
dc.publisher | Springer Japan KK | en |
dc.relation.ispartof | International Journal of Clinical Oncology | en |
dc.title | The effects of low- and high-dose-rate brachytherapy on depressive symptoms in prostate cancer patients | en |
dc.type | Journal Article | en |
dc.identifier.doi | 10.1007/s10147-013-0647-1 | en |
dc.subject.keywords | Autonomic Nervous System | en |
local.contributor.firstname | Christopher | en |
local.contributor.firstname | David R H | en |
local.contributor.firstname | Vicki | en |
local.contributor.firstname | Andrew J | en |
local.subject.for2008 | 110901 Autonomic Nervous System | en |
local.subject.seo2008 | 920111 Nervous System and Disorders | en |
local.profile.school | School of Science and Technology | en |
local.profile.school | School of Science and Technology | en |
local.profile.school | School of Science and Technology | en |
local.profile.school | Human Biology and Physiology | en |
local.profile.email | csharpl3@une.edu.au | en |
local.profile.email | dchrist2@une.edu.au | en |
local.profile.email | vbitsik2@une.edu.au | en |
local.output.category | C1 | en |
local.record.place | au | en |
local.record.institution | University of New England | en |
local.identifier.epublicationsrecord | une-20141212-170421 | en |
local.publisher.place | Japan | en |
local.format.startpage | 1080 | en |
local.format.endpage | 1084 | en |
local.identifier.scopusid | 84917672947 | en |
local.peerreviewed | Yes | en |
local.identifier.volume | 19 | en |
local.identifier.issue | 6 | en |
local.contributor.lastname | Sharpley | en |
local.contributor.lastname | Christie | en |
local.contributor.lastname | Bitsika | en |
local.contributor.lastname | Oar | en |
dc.identifier.staff | une-id:csharpl3 | en |
dc.identifier.staff | une-id:dchrist2 | en |
dc.identifier.staff | une-id:vbitsik2 | en |
local.profile.orcid | 0000-0001-7922-4848 | en |
local.profile.orcid | 0000-0003-2518-6684 | en |
local.profile.role | author | en |
local.profile.role | author | en |
local.profile.role | author | en |
local.profile.role | author | en |
local.identifier.unepublicationid | une:16553 | en |
local.identifier.handle | https://hdl.handle.net/1959.11/16316 | en |
dc.identifier.academiclevel | Academic | en |
dc.identifier.academiclevel | Academic | en |
local.title.maintitle | The effects of low- and high-dose-rate brachytherapy on depressive symptoms in prostate cancer patients | en |
local.output.categorydescription | C1 Refereed Article in a Scholarly Journal | en |
local.search.author | Sharpley, Christopher | en |
local.search.author | Christie, David R H | en |
local.search.author | Bitsika, Vicki | en |
local.search.author | Oar, Andrew J | en |
local.uneassociation | Unknown | en |
local.identifier.wosid | 000346166000015 | en |
local.year.published | 2014 | en |
local.subject.for2020 | 320903 Central nervous system | en |
local.subject.seo2020 | 200409 Mental health | en |
local.codeupdate.date | 2021-10-24T07:28:31.855 | en |
local.codeupdate.eperson | csharpl3@une.edu.au | en |
local.codeupdate.finalised | true | en |
local.original.for2020 | 320901 Autonomic nervous system | en |
local.original.seo2020 | undefined | en |
Appears in Collections: | Journal Article |
Files in This Item:
File | Description | Size | Format |
---|
SCOPUSTM
Citations
1
checked on Jun 8, 2024
Page view(s)
1,302
checked on Jun 23, 2024
Items in Research UNE are protected by copyright, with all rights reserved, unless otherwise indicated.